(Q41104944)

26 September 2017

1 reference

title

The efficacy and therapeutic position of nedocromil sodium (English)

1 reference

26 September 2017

1

Holgate ST

1 reference

26 September 2017

publication date

1 August 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

7

1 reference

26 September 2017

page(s)

391-394

1 reference

The use of twice daily nedocromil sodium in the treatment of asthma

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Treatment of nocturnal asthma with nedocromil sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Double blind, placebo controlled study of nedocromil sodium in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

The Effect of Nedocromil Sodium on Histamine Responsiveness in Clinically Stable Asthmatic Children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Effect of nedocromil sodium on aspecific bronchial hyper-reactivity in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

An overview of human safety data with nedocromil sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Anti-inflammatory effects of nedocromil sodium: inhibition of alveolar macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Evidence for the anti-inflammatory activity of nedocromil sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

The effect of nedocromil sodium on the isolated rabbit vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Nonspecific refractoriness to adenylyl cyclase stimulation in alveolar macrophages from infants with recurrent bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Albuterol and nedocromil sodium affect airway and leukocyte responses to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Inhibition of the late asthmatic response by nedocromil sodium administered more than two hours after allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990111-0

7 January 2021

10.1016/S0954-6111(96)90111-0

Identifiers

DOI

1 reference

26 September 2017

1 reference